Clinical Trial Update: Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating JTE-051 for plaque psoriasis was terminated; results posted previously.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• JTE-051

Snippet

Sponsor: Akros Pharma Inc. | Conditions: Plaque Psoriasis, Skin Diseases | Phase 2 | Status: TERMINATED | Results posted: 2021-08-06